Watch for Dovato, a New Two-Med Combo for HIV

July 2019

Dovato (doh-VAH-toh) will be a new complete HIV regimen with TWO meds in one pill...for treatment-naive patients.

It combines the integrase inhibitor dolutegravir with the nucleoside reverse transcriptase inhibitor lamivudine.

Dovato will try to compete with Biktarvy and Triumeq. These THREE-med one-pill combos have an integrase inhibitor...plus TWO nucleoSIDE/nucleoTIDE reverse transcriptase inhibitors.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Asthma Consider a PRN Combo Inhaler for Some Adults With Mild Asthma
Cardiology Optimize Meds for Peripheral Artery Disease
Diabetes Simplify Type 2 Diabetes Regimens in Older Adults
HIV & AIDS Watch for Dovato, a New Two-Med Combo for HIV
Hemorrhoids Help Patients Navigate Treatments for Hemorrhoids
Hepatitis C Be Vigilant When Starting Meds in Patients Taking Hep C Antivirals
Public Health Recognize Human Trafficking Victims Hidden in Plain Sight
Devices Put Sensors for Inhalers in Perspective
Statins Evaluate CV Risks When Considering Statins for Patients Under Age 40
Drug Costs Be Prepared for Questions About Medication Prices in TV Ads
MRSA Don't Switch From Vancomycin for MRSA Bacteremia Just for an MIC of 2 mg/L
Allergic Reactions Sort Through Options When Treating Patients Reporting a Penicillin Allergy

Watch for Dovato, a New Two-Med Combo for HIV

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents